What counseling should be provided to a 16-year-old patient starting Qelbree (viloxazine) for ADHD?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Qelbree (Viloxazine) Patient Education for a 16-Year-Old Starting Treatment

The most critical information to communicate is the FDA black box warning: Qelbree increases the risk of suicidal thoughts and behaviors, especially in the first few months of treatment or when the dose changes, requiring immediate reporting of any mood or behavioral changes. 1

Critical Safety Warnings

Suicide Risk Monitoring (BLACK BOX WARNING)

You and your family must watch closely for these warning signs, particularly in the first few weeks:

  • New or worsening depression
  • Thoughts about suicide or dying
  • Attempts to hurt yourself
  • New or worse anxiety, panic attacks, or irritability
  • Acting aggressive, angry, or violent
  • Extreme restlessness or agitation
  • Trouble sleeping (insomnia)
  • Acting on dangerous impulses
  • Extreme increase in activity or talking (mania)

Action required: Call your doctor immediately or go to the emergency room if any of these occur. Keep all scheduled follow-up appointments. 1

Other Important Safety Concerns

Blood Pressure and Heart Rate: Your doctor will check these before starting and regularly during treatment, as Qelbree can increase both. 1

Drowsiness and Fatigue: This medication commonly causes sleepiness (reported in 9.5% of patients in long-term studies). Do not drive or operate machinery until you know how Qelbree affects you. 1, 2

Mania Risk: If you have any personal or family history of bipolar disorder, depression, or mania, tell your doctor immediately, as Qelbree can trigger manic episodes. 1

How to Take Qelbree

Dosing for Adolescents (Ages 12-17)

  • Starting dose: 200 mg once daily
  • Titration: May increase to 400 mg once daily after 1 week if needed
  • Maximum dose: 400 mg once daily 1

Based on dose-response analysis, the optimal efficacy range is 200-400 mg daily, with doses above 400 mg showing no additional benefit and potentially reduced tolerability. 3, 4

Administration Instructions

  • Take once daily, with or without food
  • Swallow capsules whole (do not cut, chew, or crush)
  • Alternative if you cannot swallow: Open capsule and sprinkle entire contents on 1 tablespoon of applesauce or pudding
    • Consume within 2 hours if mixed with applesauce
    • Consume within 15 minutes if mixed with pudding
    • Do not chew the mixture
    • Do not store the mixture 1

What to Expect

Timeline for Improvement

  • Symptom improvement typically begins within the first few weeks
  • Maximum benefit usually occurs around weeks 4-6 of treatment
  • Long-term studies show continued improvement with mean ADHD symptom reduction of approximately 24-26 points on rating scales 4, 2

Efficacy

Qelbree demonstrates statistically significant ADHD symptom reduction compared to placebo (effect size of -0.33 in adolescents), though generally smaller than stimulant medications but comparable to atomoxetine. 5, 6

Common Side Effects

Most frequent adverse events (≥5% incidence):

  • Somnolence/drowsiness (9.5%)
  • Headache (8.9%)
  • Decreased appetite (6.0%)
  • Fatigue (5.7%)
  • Nausea
  • Insomnia
  • Irritability 7, 2

Most side effects are mild to moderate. Only 3.9% of patients reported severe adverse events, and 8.2% discontinued due to side effects in long-term studies. 2

Novel adverse events identified in post-marketing surveillance include:

  • Panic attacks
  • Sensory changes (hyperacusis, photophobia)
  • Behavioral changes
  • Most adverse events occur within the first 30 days 8

Absolute Contraindications - DO NOT TAKE IF:

  • Currently taking or stopped within the last 14 days: MAOIs (monoamine oxidase inhibitors - certain antidepressants)
  • Taking these specific medications: alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, or theophylline 1

Drug Interactions

Tell your doctor about ALL medications, including:

  • Over-the-counter medicines
  • Vitamins and supplements
  • Herbal products

Qelbree inhibits CYP1A2 enzyme, causing clinically significant interactions with multiple medications. Do not start any new medication without consulting your doctor first. 1

Special Considerations for Females

If you could become pregnant:

  • Qelbree may cause harm during pregnancy
  • Tell your doctor immediately if you become pregnant
  • There is a pregnancy registry available (call 1-866-961-2388)
  • Qelbree passes into breast milk 1

Missed Dose and Overdose

  • If you miss a dose, ask your doctor what to do
  • Overdose: Call poison control (1-800-222-1222) or go to the emergency room immediately 1

Follow-Up Care

  • Regular appointments are mandatory, especially in the first few months
  • Blood pressure and heart rate monitoring at each visit
  • Weight monitoring (Qelbree may affect weight)
  • Mental health symptom monitoring 1

Key Advantages of Qelbree

  • Non-stimulant option (no abuse potential)
  • Once-daily dosing
  • Generally well-tolerated long-term (up to 72 months of safety data available)
  • Effective alternative when stimulants are not tolerated or contraindicated 2, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.